Evodiamine suppresses the progression of non-small cell lung carcinoma via endoplasmic reticulum stress-mediated apoptosis pathway in vivo and in vitro .
Yuting LiYuming WangXiaoqun WangLulu JinLu YangJinli ZhuHongwu WangFang ZhengHuan-Tian CuiXiaojiang LiYingjie JiaPublished in: International journal of immunopathology and pharmacology (2022)
Our study demonstrated that EVO suppresses the progression of NSCLC by modulating the ERS-mediated apoptosis pathway.